June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Etiology, characteristics, and outcomes of oculomotor apraxia in children
Author Affiliations & Notes
  • Paul Grosrenaud
    University of Southern California Keck School of Medicine, Los Angeles, California, United States
  • Mark Borchert
    University of Southern California Keck School of Medicine, Los Angeles, California, United States
    Children's Hospital of Los Angeles, Los Angeles, California, United States
  • Melinda Chang
    University of Southern California Keck School of Medicine, Los Angeles, California, United States
    Children's Hospital of Los Angeles, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Paul Grosrenaud, None; Mark Borchert, None; Melinda Chang, None
  • Footnotes
    Support  Children’s Eye Foundation of AAPOS (MYC), Knights Templar Eye Foundation (MYC), Research to Prevent Blindness (MYC and MSB)
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 2418. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Paul Grosrenaud, Mark Borchert, Melinda Chang; Etiology, characteristics, and outcomes of oculomotor apraxia in children. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2418.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Oculomotor apraxia (OMA) is a rare disorder characterized by inability to initiate saccades. In children, OMA may be congenital and idiopathic or secondary to an underlying genetic or neurologic diagnosis. We describe clinical and radiographic findings and outcomes in children with OMA in the modern era of neuroimaging and genetic testing.

Methods : We conducted a retrospective chart review of all children (<18 years) diagnosed with OMA at our institution from 2010-2020. OMA was diagnosed in children with impaired horizontal and/or vertical saccade initiation during optokinetic nystagmus testing. Children with developmental delays underwent neuroimaging; those with additional medical comorbidities underwent genetic testing. OMA was considered improved if saccades could be generated in the affected direction with or without blinking. We compared children with congenital idiopathic OMA (CIOMA) to those with acquired or congenital OMA secondary to a genetic or neurologic disorder (SOMA).

Results : 37 patients were included. 17 (46%) were congenital and idiopathic, and 20 (54%) were secondary to a genetic or neurologic condition. Among SOMA cases, 17 (85%) had a genetic disorder (6 with Joubert syndrome), 2 had hypoxic-ischemic encephalopathy (10%), and 1 (5%) occurred after encephalitis. Neuroimaging abnormalities (90% vs. 18%, p<0.001) and developmental delays (100% vs. 59%, p=0.002) were more frequent in children with SOMA than CIOMA. Endocrine disorders (most commonly growth hormone deficiency) were diagnosed in 12% of CIOMA and 15% of SOMA cases (p=0.77). Strabismus (45% vs.12%, p=0.03), nystagmus (30% vs. 0%, p=0.02), and vertical saccade involvement (25% vs. 0%, p=0.05) were significantly more common in SOMA than CIOMA. Improvement occurred more frequently in CIOMA than SOMA (77 vs. 35%, p=0.02). Follow-up time did not significantly differ (median 3.5 vs. 3.2 years in CIOMA and SOMA groups, respectively, p=0.77).

Conclusions : Consistent with prior literature, we report a high frequency of developmental delays, neuroimaging abnormalities, and genetic and neurologic disorders in children with OMA. Additionally, we found that children with both CIOMA and SOMA had a higher rate of endocrine disorders than the general pediatric population, which has not been previously reported. Compared to children with CIOMA, those with SOMA were more likely have vertical involvement, strabismus, nystagmus, and poor oculomotor outcomes.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×